| 0 |
Anti-coagulant [EPC] |
8 |
0.0021 |
| 1 |
alpha-1 Adrenergic Agonist [EPC] |
7 |
0.0016 |
| 2 |
P2Y12 Platelet Inhibitor [EPC] |
43 |
0.0004 |
| 3 |
Antihypoglycemic Agent [EPC] |
1 |
0.0002 |
| 4 |
General Anesthetic [EPC] |
10 |
0.0002 |
| 5 |
Platelet Aggregation Inhibitor [EPC] |
54 |
0.0001 |
| 6 |
GLP-2 Analog [EPC] |
1 |
0.0001 |
| 7 |
Thrombopoietin Receptor Agonist [EPC] |
1 |
0.0001 |
| 8 |
Nitrate Vasodilator [EPC] |
5 |
0.0001 |
| 9 |
Vitamin D Analog [EPC] |
1 |
0.0001 |
| 10 |
Human Immunoglobulin G [EPC] |
1 |
0.0000 |
| 11 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
53 |
0.0000 |
| 12 |
Factor Xa Inhibitor [EPC] |
11 |
0.0000 |
| 13 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
5 |
0.0000 |
| 14 |
Opioid Agonist [EPC] |
9 |
0.0000 |
| 15 |
Penem Antibacterial [EPC] |
1 |
0.0000 |
| 16 |
BCL-2 Inhibitor [EPC] |
1 |
0.0000 |
| 17 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
2 |
0.0000 |
| 18 |
Cardiac Glycoside [EPC] |
1 |
0.0000 |
| 19 |
Proton Pump Inhibitor [EPC] |
8 |
0.0000 |
| 20 |
Androgen Receptor Inhibitor [EPC] |
1 |
0.0000 |
| 21 |
Alkylating Drug [EPC] |
3 |
0.0000 |
| 22 |
Catecholamine [EPC] |
1 |
0.0000 |
| 23 |
Dihydropyridine Calcium Channel Blocker [EPC] |
3 |
0.0000 |
| 24 |
HMG-CoA Reductase Inhibitor [EPC] |
3 |
0.0000 |
| 25 |
Fluoroquinolone Antibacterial [EPC] |
1 |
0.0000 |
| 26 |
Serotonin-3 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 27 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 28 |
Azole Antifungal [EPC] |
1 |
0.0000 |
| 29 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
1 |
0.0000 |
| 30 |
Platinum-based Drug [EPC] |
1 |
0.0000 |
| 31 |
Nucleoside Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 32 |
beta-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 33 |
CD20-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 34 |
Angiotensin 2 Receptor Blocker [EPC] |
1 |
0.0000 |
| 35 |
Corticosteroid [EPC] |
4 |
0.0000 |
| 36 |
Insulin Analog [EPC] |
1 |
0.0000 |
| 37 |
Kinase Inhibitor [EPC] |
1 |
0.0000 |